Related Content
July 1, 2019 – Biotronik announced the European market release of its new injectable cardiac monitor (ICM), Biomonitor ...
This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology ...
April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and ...
April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest implantable ...
April 15, 2019 — Biotronik began its U.S. commercial launch of the PK Papyrus covered coronary stent system for use in ...
March 15, 2019 – Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor high ...
February 22, 2019 — The U.S. Food and Drug Administration (FDA) has approved the Biotronik Orsiro drug-eluting stent ...
October 4, 2018 – Investigators unveiled clinical data from the independent BIONYX and SORT OUT IX all-comers trials ...
September 27, 2018 — Biotronik recently announced U.S. Food and Drug Administration (FDA) approval of the PK Papyrus ...
September 5, 2018 — Biotronik announced it is now the exclusive U.S. distributor for the MoMe Kardia external cardiac ...